Stay updated on Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial
Sign up to get notified when there's something new on the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page.

Latest updates to the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; 'Back to Top' element removed.SummaryDifference0.3%
- Check9 days agoChange DetectedThe page has been updated to reflect a new version and the addition of Michael Choi, while previous entries related to Benjamin Heyman have been removed.SummaryDifference2%
- Check17 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as specific medical terms related to B-cell chronic lymphocytic leukemia and associated treatments. Notably, the revision number has been updated to v3.0.0.SummaryDifference4%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.8%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.8%
- Check45 days agoChange DetectedThe web page has been updated to version v2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page.